Social and Racial Differences in Selection of Breast Cancer Adjuvant Chemotherapy Regimens

The more frequent use of non-guideline-concordant adjuvant chemotherapy regimens in black women and women with lower educational attainment may contribute to less favorable outcomes in these populations. Addressing such differences in care may improve cancer outcomes in vulnerable populations.